GeneGlobe ID: YHS-002Z | Cat. No.: | QIAseq Targeted cfDNA Ultra Panels

QIAseq Targeted cfDNA Ultra Human Colorectal Cancer Panel

Kit containing ALL reagents (except indexes) for targeted DNA sequencing
Select a variant to see the price

Product Specification

Target List
Hotspot Coverage
AKT1, APC, BRAF, CTNNB1, DPYD, EGFR (ERBB1), FBXW7, GNAS, MAP2K1, NRAS, PIK3CA (p110-alpha), RET, SMAD4 (MADH4), UGT1A1
Whole Coding Coverage
ERBB2 (HER-2, NEU), KRAS, TP53 (p53)
Adenocarcinomas
APC, BRAF, CTNNB1, EGFR (ERBB1), ERBB2 (HER-2, NEU), FBXW7, GNAS, KRAS, MAP2K1, NRAS, RET, SMAD4 (MADH4), TP53 (p53)
Metastatic Colorectal Cancers
AKT1, BRAF, CTNNB1, EGFR (ERBB1), ERBB2 (HER-2, NEU), KRAS, MAP2K1, NRAS, PIK3CA (p110-alpha), RET
Other Colorectal Cancer Genes
BRAF, CTNNB1, DPYD, EGFR (ERBB1), ERBB2 (HER-2, NEU), KRAS, MAP2K1, NRAS, PIK3CA (p110-alpha), RET, UGT1A1

Resources

Kit Handbooks (2)
For ultrasensitive targeted next-generation sequencing (NGS) of cfDNA for Illumina NGS systems
For ultrasensitive targeted next-generation sequencing (NGS) of cfDNA for Illumina NGS systems
Safety Data Sheets (1)
Certificates of Analysis (1)
Introducing the QIAseq Targeted cfDNA Ultra Human Colorectal Cancer Panel, a cutting-edge addition to our QIAseq Targeted cfDNA Ultra Panels lineup, specifically designed for NGS applications. This premium product offers unparalleled performance for researchers working with Human models. Leveraging advanced technology, the QIAseq Targeted cfDNA Ultra Human Colorectal Cancer Panel facilitates accurate and reliable results, making it an indispensable tool for your scientific investigations. Whether you're conducting NGS, or any other sophisticated analyses, this product from our QIAseq Targeted cfDNA Ultra Panels collection ensures optimal efficiency and reproducibility for Human studies. Embrace the future of research with QIAseq Targeted cfDNA Ultra Human Colorectal Cancer Panel and elevate your work to new heights.